Projects per year
Fingerprint Dive into the research topics where Andrew Brenner is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 10 Similar Profiles
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects
Omega-3 Fatty Acid Modulation of Obesity-Induced Aromatase Expression
Project: Research project
Clinical Development of Rhenium Nanoliposomes (RNL186) for Glioblastoma
Project: Research project
Novel ERbeta agonists for the treatment of gliomas
Vadlamudi, R. K., Brenner, A. J. & Brenner, A.
9/1/14 → 8/31/19
Project: Research project
Research Output
A randomized controlled phase III study of VB-111 combined with bevacizumab vs bevacizumab monotherapy in patients with recurrent glioblastoma (GLOBE)
GLOBE Study Investigators , May 15 2020, In : Neuro-oncology. 22, 5, p. 705-717 13 p.Research output: Contribution to journal › Article
Open Access
2
Scopus
citations
Everolimus inhibits the progression of ductal carcinoma in situ to invasive breast cancer via downregulation of MMP9 expression
Chen, G., Ding, X. F., Pressley, K., Bouamar, H., Wang, B., Zheng, G., Broome, L. E., Nazarullah, A., Brenner, A. J., Kaklamani, V., Jatoi, I. & Sun, L. Z., Mar 15 2020, In : Clinical Cancer Research. 26, 6, p. 1486-1496 11 p.Research output: Contribution to journal › Article
PELP1 signaling contributes to medulloblastoma progression by regulating the NF-κB pathway
Luo, Y., Li, M., Pratap, U. P., Viswanadhapalli, S., Liu, J., Venkata, P. P., Altwegg, K. A., Palacios, B. E., Li, X., Chen, Y., Rao, M. K., Brenner, A. J., Sareddy, G. R. & Vadlamudi, R. K., Mar 1 2020, In : Molecular Carcinogenesis. 59, 3, p. 281-292 12 p.Research output: Contribution to journal › Article
Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours
Hong, D. S., Kang, Y. K., Borad, M., Sachdev, J., Ejadi, S., Lim, H. Y., Brenner, A. J., Park, K., Lee, J. L., Kim, T. Y., Shin, S., Becerra, C. R., Falchook, G., Stoudemire, J., Martin, D., Kelnar, K., Peltier, H., Bonato, V., Bader, A. G., Smith, S. & 3 others, , May 26 2020, In : British Journal of Cancer. 122, 11, p. 1630-1637 8 p.Research output: Contribution to journal › Article
3
Scopus
citations
Safety and efficacy of VB-111, an anticancer gene therapy, in patients with recurrent glioblastoma: results of a phase I/II study
Brenner, A. J., Peters, K. B., Vredenburgh, J., Bokstein, F., Blumenthal, D. T., Yust-Katz, S., Peretz, I., Oberman, B., Freedman, L. S., Ellingson, B. M., Cloughesy, T. F., Sher, N., Cohen, Y. C., Lowenton-Spier, N., Rachmilewitz Minei, T., Yakov, N., Mendel, I., Breitbart, E. & Wen, P. Y., May 15 2020, In : Neuro-oncology. 22, 5, p. 694-704 11 p.Research output: Contribution to journal › Article
Open Access
1
Scopus
citations
Press / Media
Plus Therapeutics, Inc. (PSTV) CEO Marc Hedrick on Q1 2020 Results - Earnings Call Transcript
5/15/20
1 item of Media coverage
Press/Media: Press / Media
Patient Focused Presentation Supporting Brain Tumor Awareness Month
5/12/20
3 items of Media coverage
Press/Media: Press / Media
PLUS THERAPEUTICS: Licenses Novel Oncology Platform
5/12/20
1 item of Media coverage
Press/Media: Press / Media
Plus Therapeutics Announces Patient-Focused Presentation Supporting Brain Tumor Awareness Month
5/12/20
15 items of Media coverage
Press/Media: Press / Media
Plus Therapeutics Enters into Licensing Agreement with NanoTx Therapeutics
5/12/20
1 item of Media coverage
Press/Media: Press / Media